News about Drug Discovery & Development

Nona Biosciences and Umoja Biopharma Expand Partnership to Advance In-vivo CAR-T Therapies

Under the terms of the agreement, Nona Biosciences is eligible to receive an upfront payment, potential option exercise fees and milestone payments tied to the discovery and development of specific programmes in the collaboration. Umoja will be responsible for all further product development and commercialisation.

Drug Discovery & Development | 07/11/2025 | By Dineshwori |  348

IIT Madras and Ohio State Researchers Develop AI Framework That Mimics Chemical Synthesis for Drug Discovery

Researchers from the Indian Institute of Technology Madras (IIT Madras) and Ohio State University have developed an advanced artificial intelligence framework that replicates real-world chemical synthesis to accelerate drug discovery.

Drug Discovery & Development | 06/11/2025 | By Darshana |  324

AmacaThera and Pacira BioSciences Partner to Develop Long-Acting Non-Opioid Anaesthetic for Post-Operative Pain

AmacaThera, a leading biotechnology company specialising in next-generation hydrogel-based drug delivery systems, has entered into an exclusive global licensing agreement with Pacira BioSciences, Inc., a leader in non-opioid pain management, to develop and commercialise AMT-143.

Drug Discovery & Development | 05/11/2025 | By Darshana |  179

Alkem and IIT Bombay Collaborate to Launch R and D Centre for Advanced Immunotherapies

Alkem Laboratories, through its CSR arm, has partnered with IIT Bombay to establish the Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics & Regenerative Medicines on the institute’s campus.

Drug Discovery & Development | 03/11/2025 | By Darshana |  254

FDA Grants Interchangeable Status to Celltrion's Denosumab Biosimilars Stoboclo and Osenvelt

The interchangeability (IC) designation allows Stoboclo and Osenvelt to be substituted at the pharmacy level for their reference biologics without requiring prescriber consultation, in accordance with state pharmacy laws.

Drug Discovery & Development | 31/10/2025 | By Darshana |  254

Boehringer Ingelheim Acquires Licence from Kyowa Kirin to Develop Treatment for Autoimmune Diseases

Boehringer Ingelheim has acquired a licence from Kyowa Kirin to develop a small molecule programme targeting autoimmune diseases. The collaboration aims to address significant unmet medical needs and strengthen Boehringer’s pipeline of innovative therapies for patients with inflammatory and immune-related conditions.

Drug Discovery & Development | 31/10/2025 | By Dineshwori |  229

ModeX and Regeneron Partner to Develop Multispecific Antibodies

ModeX Therapeutics has entered into a research collaboration with Regeneron to develop multispecific antibodies capable of targeting multiple biological pathways within a single molecule. The partnership, valued at over USD 1 Billion, if multiple assets advance, aims to accelerate innovation across select therapeutic areas.

Drug Discovery & Development | 30/10/2025 | By Dineshwori |  303

Roche Receives CE Mark for Elecsys Dengue Antigen Test, Enhancing Global Diagnostic Capabilities

This milestone represents a significant advancement in efficiency and reliability for laboratories worldwide, helping healthcare systems address the escalating global dengue crisis.

Drug Discovery & Development | 30/10/2025 | By Darshana |  312

CEPI, SII and Oxford University Collaborate to Develop Nipah Virus Vaccine Reserve

CEPI, the Serum Institute of India, and the University of Oxford have partnered to produce ChAdOx1 NipahB vaccine doses for Phase II trials and an investigational reserve of up to 100,000 doses, ready for rapid deployment in case of a future Nipah outbreak.

Drug Discovery & Development | 30/10/2025 | By Dineshwori |  340

Biogen licences Vanqua Bio's immune-disorder drug in deal worth up to USD 1.06 billion

Biogen has entered into an agreement with Vanqua Bio to acquire global rights to an experimental oral therapy for immune-related disorders, in a deal valued at up to USD 1.06 billion.

Drug Discovery & Development | 27/10/2025 | By Darshana |  230